Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

International Journal of Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2FAtTje
via IFTTT